Kestra Advisory Services, LLC Pacira Bio Sciences, Inc. Transaction History
Kestra Advisory Services, LLC
- $17.2 Billion
- Q4 2024
A detailed history of Kestra Advisory Services, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 15,896 shares of PCRX stock, worth $404,394. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,896Holding current value
$404,394% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding PCRX
# of Institutions
253Shares Held
48.8MCall Options Held
554KPut Options Held
136K-
Black Rock Inc. New York, NY8.01MShares$204 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$134 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$83 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$57.4 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$50.7 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.17B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...